fungi,candida

Fluconazole (UK-49858) 是一种对多种真菌具有活性的三唑类抗真菌剂，抑制 C. albicans 和 Candida kefyr 的 IC99为 0.20 μg mL 至 0.39 μg mL。

Embeconazole (R 120758) 是一种三唑类抗真菌剂。Embeconazole 对念珠菌、曲霉菌、新型隐球菌等临床重要真菌具有较强的体外活性。

Lanoconazole（拉诺康唑）是一种抗真菌咪唑类药物，主要用于治疗皮肤真菌感染，具有强效和可口服的优点。通过抑制真菌细胞膜中麦角固醇的合成来发挥作用，增加真菌细胞膜的通透性，导致细胞溶解和死亡。Lanoconazole对多种病原真菌具有强效抑制作用，包括酵母菌、皮肤癣菌、霉菌、双相真菌、曲霉菌属、青霉菌属和念珠菌属。

HDM-IN-1 (Compound A4) 是一种真菌组蛋白去甲基化酶（HDM）抑制剂，能够抑制Cryptococcus neoformans和Candida auris中的H3K27me3，IC50值分别为134 nM和12 nM。此化合物通过抑制生物膜和荚膜的形成，对Cryptococcus neoformans和Candida auris显示出抗菌特性，MIC80为0.5-2 μg mL。在ICR小鼠模型中，HDM-IN-1表现出抗真菌活性。

Group II intron-IN-1 (Compound 1) 是一种抑制真菌 II 类内含子的化合物，其 IC50 为 3 μM。可用于研究由假丝酵母引起的感染性疾病。

Fluconazole 水合物是抗真菌化合物，用于治疗和预防浅表和全身性的真菌感染。

Dactylfungins A is a novel antifungal antibiotic produced by Dactylaria Parvispora. The antibiotics were active against Candida pseudotropicalis and other fungi, with a MIC value of fewer than 10 micrograms ml.

Dactylfungins B is a novel antifungal antibiotic produced by Dactylaria Parvispora. The antibiotics were active against Candida pseudotropicalis and other fungi, with a MIC value of fewer than 10 micrograms ml.

FTR1335 is a CaNMT inhibitor (IC50 = 0.49 nM) with good fungal selectivity. CaNMT inhibitors are fungicidal and show antifungal activity against Candida (especially fluconazole-resistant strains). They function by inhibiting N-myristoyltransferase (NMT), which catalyzes the transfer of a C14 fatty acif from myristoyl-CoA to the N-terminal of glycine in many fungal proteins. Without this process, fungi can die. This process also occurs in humans, and as such selectivity is an important characteristic of these drugs.

Antifungal agent 53 (A03) 是一种有效的白色念珠菌 CYP51抑制剂，具有抗真菌活性。Antifungal agent 53 阻止真菌生物膜的形成。Antifungal agent 53 也显示出良好的安全性。

Antifungalagent 73 (compound A32)是一款用于治疗唑类耐药Candida感染的抗真菌药物。该化合物通过破坏真菌的细胞壁和细胞膜来发挥作用，并且针对病原真菌和氟康唑(Fluconazole)耐药菌株显示出有效的体内抗真菌活性。